Crispr Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $9.5M | 203k | 46.98 |
| 2024-06-30 | $12M | 228k | 54.01 |
| 2024-03-31 | $15M | 216k | 68.16 |
| 2023-12-31 | $11M | 168k | 62.60 |
| 2023-09-30 | $9.2M | 203k | 45.39 |
| 2023-06-30 | $11M | 200k | 56.14 |
| 2022-12-31 | $5.6M | 137k | 40.65 |
| 2022-09-30 | $9.0M | 140k | 64.52 |
| 2022-06-30 | $8.4M | 139k | 60.77 |
| 2022-03-31 | $12M | 196k | 62.78 |
| 2021-12-31 | $15M | 192k | 75.77 |
| 2021-09-30 | $52M | 463k | 111.75 |
| 2021-06-30 | $76M | 467k | 162.00 |
| 2021-03-31 | $46M | 380k | 121.85 |
| 2020-12-31 | $71M | 465k | 153.11 |
| 2020-09-30 | $47M | 561k | 83.64 |
| 2020-06-30 | $40M | 542k | 73.49 |
| 2020-03-31 | $21M | 502k | 42.41 |
| 2019-12-31 | $25M | 407k | 60.90 |
| 2019-09-30 | $21M | 521k | 40.99 |
| 2019-06-30 | $28M | 604k | 47.10 |
| 2019-03-31 | $17M | 487k | 35.72 |
| 2018-12-31 | $14M | 475k | 28.57 |
| 2018-09-30 | $19M | 429k | 44.35 |
| 2018-06-30 | $21M | 364k | 58.76 |
| 2018-03-31 | $21M | 461k | 45.71 |
| 2017-12-31 | $505k | 22k | 23.47 |
| 2017-06-30 | $139k | 8.0k | 17.39 |
| 2017-03-31 | $31k | 1.4k | 21.74 |
| 2016-12-31 | $21k | 980 | 21.74 |